Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B

Stopped Not possible to complete the sample within the estimated time by the use of new antifungals

Conditions

• Patients With Fungic Infections

Interventions

• DRUG: Spironolactone 100mg
• DRUG: Spironolactone 200mg
• DRUG: Placebo

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran